Literature DB >> 483198

Effect of hyperlipidaemia on pulmonary diffusing capacity for carbon monoxide.

M R Partridge, J M Hughes, G R Thompson.   

Abstract

There is conflicting evidence on the effect of hyperlipidaemia on pulmonary diffusing capacity for carbon monoxide (DLCO or TLCO) in man. We have measured the carbon monoxide transfer factor per unit alveolar volume (TLCO/VA or KCO) by the single breath method in 25 patients with hyperlipidaemia, and in three normal subjects before and after infusions of an intravenous fat emulsion, Intralipid. Non-smokers with hyperlipidaemia had normal levels of TLCO/VA, whereas some of the smokers showed a slight reduction. In neither group was there any correlation of TLCO/VA with serum triglyceride or cholesterol concentrations. A reduction in triglyceride concentrations of up to five-fold produced by plasma exchange (three studies in two patients) or by dietary manipulation (one patient) had no significant effect on the levels of TLCO/VA. Intralipid infusion in three normal subjects caused a four- to five-fold increase in serum triglyceride concentration but had no effect on TLCO/VA. We conclude that moderate degrees of hyperlipidaemia have no effect on pulmonary diffusion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 483198      PMCID: PMC471052          DOI: 10.1136/thx.34.2.265

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Authors:  W S BLAKEMORE; R E FORSTER; J W MORTON; C M OGILVIE
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

2.  Effect of elevated triglycerides on the diffusing capacity of man.

Authors:  H H Newball; W T Friedewald; B Roberts; R I Levy; C J Lenfant
Journal:  Am Rev Respir Dis       Date:  1975-07

3.  Decrease in pulmonary diffusing capacity during lipid infusion in healthy men.

Authors:  G Sundström; C W Zauner; M Arborelius
Journal:  J Appl Physiol       Date:  1973-06       Impact factor: 3.531

4.  Disturbances in pulmonary gaseous exchange in primary hyperlipoproteinemias.

Authors:  G Enzi; M Bevilacqua; G Crepaldi
Journal:  Bull Eur Physiopathol Respir       Date:  1976 May-Jun

5.  Relationship between Intralipid-induced hyperlipemia and pulmonary function.

Authors:  H L Greene; D Hazlett; R Demaree
Journal:  Am J Clin Nutr       Date:  1976-02       Impact factor: 7.045

6.  Pulmonary vascular effects of fat emulsion infusion in unanesthetized sheep. Prevention by indomethacin.

Authors:  C R McKeen; K L Brigham; R E Bowers; T R Harris
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

  6 in total
  1 in total

1.  Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.

Authors:  Kathrin Kahnert; Tanja Lucke; Rudolf M Huber; Jürgen Behr; Frank Biertz; Anja Vogt; Henrik Watz; Peter Alter; Sebastian Fähndrich; Robert Bals; Rolf Holle; Stefan Karrasch; Sandra Söhler; Margarethe Wacker; Joachim H Ficker; Klaus G Parhofer; Claus Vogelmeier; Rudolf A Jörres
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.